Epididymitis after prostate brachytherapy

Urology

Volumn 63, Issue 2, 2004, Pages 293-296

  Hoffelt, S Christopher ^b   Wallner, Kent ^a   Merrick, Gregory ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; IODINE 125; PALLADIUM 103;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIDIDYMITIS; FOLLOW UP; HUMAN; INCIDENCE; INTERVIEW; MALE; MORBIDITY; ORGAN SIZE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CARCINOMA; QUESTIONNAIRE; RADIOISOTOPE THERAPY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 1242319247     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.09.021     Document Type: Article

References (23)

1. Wallner K., Blasko J., Dattoli M. Morbidity. Dattoli M. Prostate Brachytherapy Made Complicated. 2nd ed:2001;SmartMedicine Press, Seattle. pp. 15.1-15.21.
2. Hughes S., Wallner K., Miller G., et al. Pre-existing histologic evidence of prostatitis is unrelated to post-implant urinary morbidity. Radiat Oncol Invest. 96:(suppl):2001;79-82.
3. Wallner K.E., Smathers S., Sutlief S., et al. Prostate brachytherapy in patients with median lobe hyperplasia. Int J Cancer. 90:2000;152-156.
4. Merrick G., Butler W., Wallner K., et al. Dysuria following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 55:2003;979-985.
5. Merrick G.S., Wallner K.E., Butler W.M., et al. Short-term sexual function after prostate brachytherapy. Radiat Oncol Invest. 96:2001;313-319.
6. Wallner K, Elliott K, Merrick G, et al: Chronic pelvic pain following prostate brachytherapy. Brachytherapy (in press).
7. Nguyen J., Wallner K., Han B., et al. Increased long-term urinary morbidity in brachytherapy patients with median lobe hyperplasia. Brachytherapy. 1:2002;42-47.
8. Uchida T., Ohori M., Soh S., et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 53:1999;98-105.
9. Collins G.N., Lloyd S.N., Hehir M., et al. Multiple transrectal ultrasound-guided prostatic biopsies - true morbidity and patient acceptance. Br J Urol. 71:1993;460-463.
10. Wallner K., Merrick G., True L., et al. I-125 versus Pd-103 for low risk prostate cancer morbidity outcomes from a prospective randomized multicenter trial . Cancer J Sci Am. 8:2002;67-73.
11. Ghaly M., Wallner K., Merrick G., et al. The effect of supplemental beam radiation on prostate brachytherapy-related morbidity morbidity outcomes from two prospective randomized multicenter trials . Int J Radiat Oncol Biol Phys. 55:2003;1288-1293.
12. Merrick G.S., Butler W.M. Modified uniform seed loading for prostate brachytherapy rationale, design, and evaluation . Techn Urol. 6:2000;78-84.
13. Han B., Wallner K., Aggarwal S., et al. Treatment margins for prostate brachytherapy. Semin Urol Oncol. 18:2000;137-141.
14. Badiozamani K.R., Wallner K.E., Cavanagh W., et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys. 43:1999;375-378.
15. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1957.
16. Antolak S.J., Hough D.M., Pawlina W. The chronic pelvic pain syndrome after brachytherapy for carcinoma of the prostate. J Urol. 167:2002;2525.
17. Davis B.J., Pfeifer E.A., Wilson T.M., et al. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol. 164:2000;1661.
18. Barker J., Wallner K., Merrick G. Gross hematuria after prostate brachytherapy. Urology. 61:2003;408-411.
19. Long J.P., Fallick M.L., LaRock D.R., et al. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol. 159:1998;477-484.
20. Bannerman C., Wagner W.W. Prophylaxis of postoperative epididymitis. Urology. 20:1982;488-490.
21. Egawa S., Uchide T., Kawakami T., et al. Neodymium YAG laser ablation of the prostate gland - acute perioperative morbidity and short-term outcome . Int J Urol. 1:1994;246-251.
22. Dicker A.P., Figura A.T., Waterman F.M., et al. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Techn Urol. 6:2000;104-108.
23. Wallner K.E., Roy J., Harrison L. Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 36:1996;681-683.